China runs one of the largest and most complex equity markets in the world — spread across three exchanges, split into onshore and offshore shares, and tracked by a long list of indices that can be confusing even to experienced investors. Its benchmarks have been in focus through 2026, with mainland A-shares climbing to multi-year highs and a technology-led rally lifting both Shanghai’s STAR Market and Hong Kong’s tech names. This guide explains the major China stock market indices — the CSI 300, the Shanghai (SSE) Composite, the Shenzhen Component and ChiNext, the STAR 50, the FTSE China A50, the Hang Seng family and MSCI China — what each one actually tracks, how A-shares, H-shares and ADRs differ, and the main ways a Singapore investor can get exposure. It is for educational purposes only and is not a recommendation to buy or sell any security.
What are China’s stock market indices?
A stock market index is a basket of shares used to measure how a market, or a slice of it, is performing. China is unusual in having three main listing venues, and the major indices map onto them:
- Shanghai Stock Exchange (SSE) — home to many of China’s largest state-owned enterprises, banks and industrial firms, plus the tech-focused STAR Market.
- Shenzhen Stock Exchange (SZSE) — weighted towards smaller, private, growth and technology companies, and home to the ChiNext board.
- Hong Kong Stock Exchange (HKEX) — a separate, international market where many large Chinese companies list for access to global capital.
The other thing that makes China distinctive is its share classes. Companies can list shares in different places and currencies — A-shares on the mainland (in renminbi), H-shares in Hong Kong (in Hong Kong dollars), and ADRs in the United States (in US dollars). Which index you look at depends on which of these slices of the market you want to measure.
Because of this structure, there is no single “China index” the way the Straits Times Index represents Singapore. Instead there is a family of benchmarks, each with a different job.
The major China stock market indices
Here is how the headline indices compare. The table focuses on what each index tracks (which is evergreen); live levels and 2026 returns are in the dated snapshot further down, because they change daily.
| Index | Market / board | What it tracks | Currency |
|---|---|---|---|
| CSI 300 | Shanghai + Shenzhen (A-shares) | The 300 largest, most liquid A-shares across both mainland exchanges — China’s main large-cap benchmark | CNY |
| SSE Composite | Shanghai | All stocks listed on the Shanghai Stock Exchange — the most-quoted “China market” headline number | CNY |
| Shenzhen Component | Shenzhen | 500 representative stocks on the Shenzhen exchange — more growth- and tech-tilted | CNY |
| ChiNext (創業板) | Shenzhen (ChiNext board) | Growth, start-up and innovation companies on Shenzhen’s ChiNext board | CNY |
| STAR 50 | Shanghai (STAR Market) | The 50 largest companies on the SSE’s science-and-technology STAR Market | CNY |
| FTSE China A50 | Shanghai + Shenzhen (A-shares) | The 50 largest A-share companies — widely used by foreign investors and futures markets | CNY |
| Hang Seng Index (HSI) | Hong Kong | The largest companies listed in Hong Kong, including many mainland Chinese giants | HKD |
| Hang Seng China Enterprises (HSCEI) | Hong Kong | Mainland Chinese companies listed in Hong Kong — the “H-share” benchmark | HKD |
| Hang Seng TECH | Hong Kong | The largest technology companies listed in Hong Kong — the “Nasdaq of Hong Kong” | HKD |
| MSCI China | Onshore + offshore | A broad global benchmark spanning H-shares, ADRs and large-/mid-cap A-shares | USD |
Index names and definitions are illustrative, not recommendations. Constituent counts are maintained by each index provider and reviewed periodically.
CSI 300 — the headline large-cap benchmark. The index most professionals treat as the benchmark for mainland China. Compiled by China Securities Index Co., it holds the 300 largest and most liquid A-shares across Shanghai and Shenzhen, spanning finance, consumer, industrials and technology. It is the index most foreign-accessible China A-share funds aim to track.
SSE Composite — Shanghai’s headline number. Tracks every stock listed on the Shanghai Stock Exchange, so it is the “China market” figure most people see in a headline. Heavy on banks, energy and large state-owned enterprises, it behaves differently from the growth-tilted Shenzhen indices.
Shenzhen Component and ChiNext — the growth side. The Shenzhen Component tracks 500 representative companies that skew towards private, consumer-tech and manufacturing firms. Within Shenzhen, the ChiNext Index covers younger, higher-growth companies — higher potential, but typically higher volatility than the large-cap CSI 300.
STAR 50 — Shanghai’s tech-growth board. Tracks the 50 largest names on the SSE’s STAR Market (the Science and Technology Innovation Board), launched in 2019 for semiconductor, AI, biotech and advanced-manufacturing companies. It was one of the most closely watched China indices in 2026 as capital rotated into the AI and chip supply chain — a rally that also pushed valuations to demanding levels.
FTSE China A50 — the foreign-access A-share gauge. Holds the 50 largest A-share companies and is widely used by overseas investors, partly because it underpins liquid index futures traded in Singapore and Hong Kong.
Hang Seng Index, HSCEI and Hang Seng TECH — China via Hong Kong. Many of China’s biggest companies list in Hong Kong. The Hang Seng Index (HSI) tracks Hong Kong’s largest listed companies; the Hang Seng China Enterprises Index (HSCEI) isolates the mainland companies listed there — the classic “H-share” benchmark; and the Hang Seng TECH Index tracks Hong Kong’s largest technology names. (As of October 2026, the index provider announced plans to expand Hang Seng TECH from 30 to 50 constituents — confirm the effective date at publish.)
MSCI China — the global investor’s China benchmark. The benchmark many international and emerging-market funds measure against. It is deliberately broad, spanning H-shares, US-listed ADRs and a portion of mainland A-shares, and is quoted in US dollars. If you hold a global or emerging-market ETF, your China exposure is most likely benchmarked to something close to MSCI China.
A-shares, H-shares and ADRs — what’s the difference?
Because the same Chinese company can be listed in more than one place, it helps to know which “China” you are buying. This is one of the most-searched points of confusion about the Chinese market.
| Share class | Where it trades | Currency | Who can easily buy it |
|---|---|---|---|
| A-shares | Shanghai & Shenzhen (mainland) | Renminbi (CNY) | Mainland investors; foreigners mainly via Stock Connect, QFII or A-share ETFs |
| H-shares | Hong Kong (HKEX) | Hong Kong dollar (HKD) | Any investor with access to the Hong Kong market |
| ADRs | United States (NYSE / Nasdaq) | US dollar (USD) | Any investor with access to US markets |
A few practical implications:
- A-shares are the largest pool and the one most “China domestic” indices (CSI 300, SSE Composite, STAR 50, FTSE China A50) are built from. For most retail investors outside China, the simplest route is an A-share ETF.
- H-shares and other Hong Kong listings (tracked by the HSI, HSCEI and Hang Seng TECH) are far easier for international investors to access directly.
- ADRs let you buy large Chinese companies in US dollars on US exchanges, though they carry their own regulatory considerations.
The same company can trade at different prices in different venues, which is why the mainland and Hong Kong indices do not move in lockstep.
China stock market performance in 2026
The figures below are indicative, drawn from public data as of late October 2026, and change continuously. Verify the current level before making any decision.
2026 has been a notably strong year for Chinese equities. Mainland A-shares pushed to multi-year highs early in the year and have broadly held those gains, while a technology- and AI-led rally — helped by renewed interest in Chinese AI models and the domestic chip supply chain — lifted Shanghai’s STAR Market and Hong Kong’s tech names in particular. Major banks entered 2026 constructive on Chinese equities, with some forecasting high-single-digit to around 20% upside for the year, while others flagged stretched valuations in the hottest pockets of the market.
| Index | Approx. level (late Oct 2026) | Note |
|---|---|---|
| CSI 300 | ~4,000+ | Near multi-year highs on an A-share recovery |
| SSE Composite | ~3,700 | Reached decade highs during 2026 before consolidating |
| STAR 50 | — | A standout performer (reported up ~29% YTD) on the AI/chip theme; valuations rich |
| Hang Seng Index | ~24,000 | Strong 2026 recovery led by technology and renewed foreign interest |
All four figures must be re-checked and re-dated on publish day. The Shenzhen Component, ChiNext, HSCEI, Hang Seng TECH, FTSE China A50 and MSCI China all participated in the 2026 rally to varying degrees.
The important caveat: a strong year is not a forecast. Chinese equities have historically been more volatile than developed markets and sensitive to policy shifts, which is why index levels and valuations deserve a fresh look before you invest.
How to invest in China’s stock market from Singapore
For a Singapore-based investor, there are three broad ways to get exposure to China’s indices, each suiting a different level of involvement. (If you want to understand individual Chinese companies and themes rather than the indices, see our companion guide, how Singapore investors can approach China stocks.)
- China index ETFs. The simplest way to track a China index is an exchange-traded fund built to follow it — A-share ETFs that track the CSI 300 or FTSE China A50, broad-China ETFs benchmarked to MSCI China, or Hong Kong tech ETFs that follow the Hang Seng TECH. One trade buys the whole basket. See our guide to ETF investing in Singapore for how ETFs work and what to check.
- Individual Chinese stocks. You can also buy individual Chinese companies directly — most accessibly through their Hong Kong (H-share) or US (ADR) listings. This gives you full control but requires research and concentrates risk in single names.
- A diversified or managed portfolio. If you would rather not pick China exposure yourself, a globally diversified portfolio holds China as one part of a wider mix. This is how many long-term investors take on China — as a slice of a diversified portfolio rather than a standalone bet.
With Syfe Brokerage you can access US- and Hong Kong-listed China and China-tech ETFs, along with individual H-share and ADR listings, from a single account. If you prefer a hands-off approach, Syfe’s globally diversified managed portfolios include China within their broader global and emerging-market exposure, so you get a measured allocation without having to size it yourself. For how China fits alongside a home-market core, see our guide to the Singapore stock market.
Is investing in China’s stock market a good idea?
Whether China exposure suits you depends on your goals, time horizon and risk tolerance, and it is best weighed as strengths against trade-offs rather than a simple yes or no.
The case for. China is the world’s second-largest economy and its equity market offers exposure to sectors — electric vehicles, semiconductors, AI, e-commerce and advanced manufacturing — that are harder to access elsewhere. Valuations have often been lower than in developed markets, and because Chinese equities do not always move in step with US or European markets, a modest allocation can add diversification to a global portfolio.
The trade-offs. China’s market is more volatile and more sensitive to policy and regulatory shifts than most developed markets. The onshore/offshore structure adds complexity, foreign access to A-shares is less direct, and currency and geopolitical factors can weigh on returns. The 2026 rally has also left parts of the market — notably the hottest tech and STAR Market names — trading at demanding valuations, which raises the risk of sharp pullbacks.
For these reasons, many investors treat China as a satellite position — a deliberate, sized slice of a diversified portfolio — rather than a core holding. The right amount, if any, is a personal decision.
Risks to consider
No equity market is without risk, and China’s has some specific ones worth keeping in mind:
- Volatility — Chinese indices have historically swung more sharply than developed-market benchmarks, both up and down.
- Policy and regulatory risk — government policy, regulatory changes and stimulus decisions can move the market quickly and are hard to predict.
- Valuation risk — after a strong 2026, some segments (especially tech/STAR names) trade at high valuations, which can amplify any correction.
- Access and structure — A-share access is less direct for foreign investors, and the same company can trade at different prices across venues.
- Currency and geopolitical risk — renminbi moves and international tensions can affect returns for an SGD-based investor.
- Market risk — prices fall as well as rise, and 2026’s strong run is not a guide to future results.
Diversification, position sizing and a long-term horizon are the main defences.
Frequently asked questions
The headline ones are the CSI 300 (the 300 largest mainland A-shares), the SSE Composite (all Shanghai-listed stocks), the Shenzhen Component and ChiNext (growth and tech on the Shenzhen exchange), the STAR 50 (Shanghai’s tech-growth board), the FTSE China A50 (50 largest A-shares, popular with foreign investors), and the Hong Kong-based Hang Seng Index, HSCEI and Hang Seng TECH. MSCI China is the broad benchmark most global funds track.
The CSI 300 is China’s main large-cap benchmark. It tracks the 300 largest and most liquid A-shares listed in Shanghai and Shenzhen, and is the index most foreign-accessible China A-share funds aim to follow.
The SSE Composite includes every stock on the Shanghai exchange only, so it is heavy on large state-owned banks and industrials. The CSI 300 is a selective large-cap index spanning both Shanghai and Shenzhen, so it is more diversified across the mainland market.
A-shares trade on the mainland in renminbi, H-shares are mainland companies listed in Hong Kong in Hong Kong dollars, and ADRs are Chinese companies listed in the US in US dollars. They represent the same market from different venues and currencies, and are not always priced identically.
The most straightforward route is a China index ETF — for example an A-share ETF tracking the CSI 300 or FTSE China A50, a broad-China ETF tracking MSCI China, or a Hong Kong tech ETF tracking the Hang Seng TECH. You can access these, along with H-share and ADR listings, through a brokerage account, or hold China as part of a globally diversified managed portfolio.
It offers access to large, fast-moving sectors and can add diversification to a global portfolio, often at lower valuations than developed markets. But it is more volatile and more exposed to policy and regulatory shifts, and parts of the market look expensive after 2026’s rally. Many investors hold it as a sized satellite position rather than a core holding. This is general information, not advice.
2026’s strength was driven mainly by a technology- and AI-led rally — including renewed interest in Chinese AI and the domestic semiconductor supply chain — alongside supportive policy and an earnings recovery, which lifted mainland A-shares to multi-year highs and buoyed Hong Kong’s tech names. Past performance is not a guide to future results.
Read more
- How Singapore Investors Can Approach China Stocks: Themes, Risks and Notable Names
- ETF Investing in Singapore: A Practical Guide for Beginners
- The Singapore Stock Market: A Beginner’s Guide to Investing on the SGX
- Best Dividend Stocks in Singapore
Disclaimer
This article is provided by Syfe Pte. Ltd. for general information and educational purposes only. It is not financial advice and does not constitute a recommendation, offer or solicitation to buy or sell any security or investment product. Investments carry risk, including the possible loss of principal, and past performance is not indicative of future results. Investing in overseas markets, including China, involves additional risks such as currency, liquidity, regulatory and geopolitical risk. Market figures, index levels and returns quoted are indicative only, based on publicly available data as at the stated date, and change with market conditions. You should consider your own objectives, financial situation and needs — and seek independent advice where appropriate — before making any investment decision.
Syfe Pte. Ltd. is regulated by the Monetary Authority of Singapore (Capital Markets Services Licence No. CMS100837). This advertisement has not been reviewed by the Monetary Authority of Singapore.
